Latest news and press releases about Myomo, Inc. (MYO): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities.
Price
| Price | $1.29 |
| Market Cap | $50M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 9.45 |
| EV / EBITDA | -5.66 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -142.02% |
| Return on Invested Capital | -45.17% |
| Return on Assets | -41.05% |
| Gross Margin | 68.35% |
| Operating Margin | -27.05% |
| Net Margin | -33.53% |
Related companies: ECOR · HYPD · IGC · MIRA · MLSS · MODD · NMTC
Explore sector: Healthcare · Medical - Devices
More sections of MYO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks